ƽ

ImmunoCult™ NK Cell Expansion Kit

Kit for the culture and expansion of human NK cells

ImmunoCult™ NK Cell Expansion Kit

Kit for the culture and expansion of human NK cells

Catalog #
(Select a product)
Kit for the culture and expansion of human NK cells
Request Pricing Request Pricing

Product Advantages


  • Robust expansion of NK cells with high yield and frequency

  • Feeder- and serum-free culture conditions

  • Expanded NK cells are functional with cytotoxic potential

What's Included

  • ImmunoCult™ NK Cell Base Medium, 500 mL (Catalog #100-0712)
  • ImmunoCult™ NK Cell Expansion Supplement, 5 mL (Catalog #100-0715)
  • ImmunoCult™ NK Cell Expansion Coating Material, 1.5 mL (Catalog #100-0714)
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Consistently expand natural killer (NK) cells in serum-free conditions without the use of problematic feeder cells.

Use ImmunoCult™ NK Cell Expansion Kit to provide optimized culture conditions for expanding NK cells with high yields. This kit comprises ImmunoCult™ NK Cell Base Medium, ImmunoCult™ NK Cell Expansion Supplement, and ImmunoCult™ NK Cell Expansion Coating Material, providing you with a complete, easy-to-use culture system. After just 14 days in culture, cells can be harvested and used directly in your downstream applications.

This kit is compatible with many of our other upstream and downstream products. For example, you can use ⳧™ cell separation kits to isolate NK cells that can then be immediately expanded using ImmunoCult™ NK Cell Expansion Kit.
Subtype
Specialized Media
Cell Type
NK Cells
Species
Human
Application
Cell Culture, Expansion
Brand
ImmunoCult
Area of Interest
Cancer, Immunology, Cell Therapy Development
Formulation Category
Animal Component-Free, Serum-Free, Xeno-Free

Data Figures

Protocol for the Expansion of Natural Killer (NK) Cells Using the ImmunoCult™ NK Cell Expansion Kit

Figure 1. ImmunoCult™ NK Cell Expansion Protocol

Human natural killer (NK) cells are isolated from blood or leukapheresis using ⳧™ selection. The NK cells are cultured in ImmunoCult™ NK Cell Expansion Medium, on plates coated with ImmunoCult™ NK Cell Expansion Coating Material. After 3 days, fresh medium is added to the culture. On day 7, and again on day 10 or 11, expanding NK cells are harvested and replated on freshly coated plates. Expanded NK cells were harvested on day 14 for use in downstream assays.

Cell Frequency, Fold Expansion, and Phenotyping of Natural Killer (NK) Cells Cultured Using the ImmunoCult™ NK Cell Expansion Kit

Figure 2. CD56+CD3− NK Cells Expand Over 14 Days in Feeder- and Serum-Free Culture Conditions

Isolated human CD56+CD3− NK cells were cultured using ImmunoCult™ NK Cell Expansion Kit for 14 days (Figure 1). Cells were harvested and analyzed for expression of characteristic NK cells markers, including CD56, CD3, CD16, CD94, KIR, NKG2D, NKp46, NKp30, and NKp44 by flow cytometry. Staining for killer cell immunoglobulin-like receptor (KIR) molecules was performed using two different antibody clones, HP-MA4 and 180704, which recognize distinct KIR molecules. Dead cells were excluded by light-scatter profile and DRAQ7™ staining. (A - H) Representative flow cytometry plots. (I) The average frequencies of viable CD56+CD3− and CD56+CD16+ NK cells on day 14 were 87 ± 1% and 75 ± 2%, respectively. The average fold expansion of CD56+CD3− cells was 89 ± 17. Results shown represent mean ± SEM (n = 34).

Cytotoxicity of Expanded Natural Killer (NK) Cells Co-Cultured with K562 Cells

Figure 3. Expanded NK Cells Are Functional, Killing K562 Cells in Co-Culture

Isolated CD56+CD3− NK cells were expanded as described in Figure 1. Expanded NK cells were co-cultured with Incucyte® Cytolight Rapid Dye-labeled K562 cells at 1:1 ratio of NK:K562 cells at 37°C for 4 hours. Incucyte® Caspase-3/7 Dye, a caspase-inducible dye, was added to the co-culture to detect caspase-induced apoptosis of the K562 cells. Images were obtained every hour using the Incucyte® imaging system and then analyzed to determine % killing (# apoptotic K562 cells ÷ # total labeled K562 cells). After 4 hours, an average of 48 ± 2.4% K562 cells were killed (n = 9). Data represent mean ± SEM.

Degranulation and Cytokine Production in Stimulated Natural Killer (NK) Cells Expanded Using the ImmunoCult™ NK Cell Expansion Kit

Figure 4. Expanded NK Cells Degranulate and Produce Cytokines After Stimulation

Isolated CD56+CD3− NK cells were expanded for 14 days (Figure 1). Expanded NK cells were left unstimulated (control) or were stimulated with either phorbol 12-myristate 13-acetate (PMA) and ionomycin or K562 cells at a ratio of 1:1 effector:target cells. CD107a antibody was added, and cultures were incubated at 37°C for 4 hours. After the first hour, Monensin and Brefeldin A were added. Cells were assessed for surface CD56, CD107a, and intracellular IFN-γ and TNF-α expression by flow cytometry. (A-C) Representative histograms of CD107a, IFN-γ, and TNF-α expression of unstimulated (grey filled), PMA and ionomycin-stimulated (orange), and K562-stimulated (purple) NK cell samples. (D) The average frequency of NK cells expressing surface CD107a, a marker of degranulation, was 23 ± 5% for the unstimulated control, 88 ± 5% after stimulation with PMA and ionomycin, and 74 ± 6% after stimulation with K562 cells. (E) The average frequency of NK cells expressing intracellular IFN-γ was 10 ± 2% for the unstimulated control, 75 ± 4% for cells stimulated with PMA and ionomycin, and 48 ± 4% for cells co-cultured with K562 cells. (F) The average frequency of NK cells expressing intracellular TNF-α was 6 ± 4% for the unstimulated control, 85 ± 1% cells stimulated with PMA and ionomycin, and 45 ± 4% for cells co-cultured with K562 cells. Data represent mean ± SEM (n = 6 - 13).

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
100-0711
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0715
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0712
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0714
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0711
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0711
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0711
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0715
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0712
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-0714
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (5)

Attenuation of natural killer cell cytotoxicity by interaction between NKp30 of NK cells and dipeptidase 1 of colon cancer cells Kim et al. Scientific Reports 2025 Oct

Abstract

Natural killer (NK) cells play a crucial role in immune surveillance by recognizing and eliminating tumor cells. However, tumors employ various mechanisms to evade NK cell-mediated immunity. NKp30 is a potent activating receptor on NK cells, but its function can be inhibited by specific ligands secreted by cancer cells. Here, we identified dipeptidase 1 (DPEP1) as a novel ligand for NKp30 in KM12C colon cancer cells, using co-immunoprecipitation, confocal microscopy, and flow cytometry. We examined how the DPEP1–NKp30 interaction affects NK cell activity and found that NK cytotoxicity increased in KM12C cells with DPEP1 knockdown but was significantly reduced in HCT116 cells overexpressing DPEP1. We further demonstrated that DPEP1 is secreted via extracellular vesicles and that its interaction with NKp30 suppressed the expression and secretion of perforin 1, granzyme B, CD107a, and interferon-γ in NK92 cells. In a xenograft mouse model treated with NK92 cells, tumors derived from HCT116/DPEP1 cells were significantly larger than those from HCT116/mock cells. Using peripheral blood-derived human NK cells, we confirmed that DPEP1 inhibited both cytotoxicity and granzyme B secretion. These findings suggest that disrupting the DPEP1–NKp30 interaction may enhance NK cell-mediated cytotoxicity and represent a novel therapeutic strategy for cancer immunotherapy. The online version contains supplementary material available at 10.1038/s41598-025-18475-z.
Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition Scientific Reports 2025 Jul

Abstract

Aging is associated with immune dysfunction, but long-term endurance training may confer protective effects on immune cell function. This study investigates how natural killer (NK) cell phenotypes, functional markers, and metabolism differ between endurance-trained and untrained older adults. Ex vivo expanded NK cells from endurance-trained (63.6 ± 2.1 years) and untrained (64.3 ± 3.3 years) males were exposed to adrenergic blockade (propranolol; 0–200 ng/mL) or mTOR inhibition (rapamycin; 10–100 ng/mL), both with or without PMA-induced inflammatory stimulation. Flow cytometry assessed NK subsets, activation (CD38, CD57, CD107a, NKG2D), senescence (KLRG1), and inhibitory markers (PD-1, LAG-3, TIM-3, NKG2A). Seahorse analysis measured metabolic parameters. Trained participants displayed healthier immune profiles (lower NLR, SII) and higher effector NK cells with lower cytotoxic subsets. Propranolol at 100 ng/mL blunted PMA-driven increases in CD57, CD107a, and NKG2D, while potentiating regulatory markers KLRG1, LAG-3, and PD-1 in the trained group, indicating stronger immunoregulation. With rapamycin, trained NK cells preserved NKG2D and CD107a at 10 ng/mL, maintaining cytotoxicity and degranulation. In contrast, at 100 ng/mL rapamycin plus PMA, trained NK cells shifted toward an effector phenotype with higher CD57 and CD107a, yet a blunted PMA-increased LAG-3 and TIM-3, suggesting resistance to exhaustion. PD-1 and KLRG1 remained elevated, reflecting balanced immune control. Mitochondrial analysis revealed that trained NK cells exhibited higher basal and maximal OCR, greater spare respiratory capacity, and OCR/ECAR ratio, reflecting superior metabolic fitness. These findings indicate that endurance-trained older adults have NK cells with greater functional adaptability, reduced senescence, and enhanced metabolism under inflammatory and pharmacological stress.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-025-06057-y.
Evaluating the Influence of Different Serum‐Free Culture Conditions on the Production and Function of Natural Killer Cell‐Derived Extracellular Vesicles Y. Wu et al. Journal of Extracellular Biology 2025 Apr

Abstract

Natural killer (NK) cells are exploited in cellular therapies for cancer. While NK cell therapies are efficient against haematological cancers, it has been difficult to target solid tumours due to low tumour infiltration and a hostile tumour microenvironment. NK‐cell derived extracellular vesicles (NK‐EVs) target and kill cancer cells in vitro and represent an alternative treatment strategy for solid tumours. To exploit their potential, it is necessary to standardize NK‐EV production protocols. Here, we have performed a comparative analysis of EVs from the human NK‐92 cell line cultured in five serum‐free commercial media optimized for growth of human NK cells and one serum‐free medium for growth of lymphocytes. The effect of growing the NK‐92 cells in static cell cultures versus shaking flasks was compared. EVs were purified via ultracentrifugation followed by size‐exclusion chromatography. We found that there were no significant differences in EV yield from NK‐92 cells grown under static or dynamic conditions. However, we found clear differences between the different culture media in terms of EV purity as assessed by the enrichment of the CD63 and CD81 markers in the isolates that translated into their capacity to induce apoptosis of the colon cancer cell line HCT 116. These findings will be instructive for the design of future production protocols for therapeutic NK‐cell derived EVs.